Barclays PLC Amarin Corp Plcuk Put Options Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 13, 2021	SELL	$5.03 - $8.8 $417,490 - $730,400	-83,000 Reduced 80.27%	20,400 $127,000
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $72,800 - $155,200	-20,000 Reduced 16.21%	103,400 $435,000
Q2 2020 Aug 12, 2020	SELL	$4.78 - $8.26 $3.82 Million - $6.6 Million	-798,500 Reduced 86.61%	123,400 $854,000
Q1 2020 May 13, 2020	BUY	$4.0 - $21.53 $1.35 Million - $7.29 Million	338,600 Added 58.05%	921,900 $3.69 Million
Q4 2019 Feb 10, 2020	BUY	$13.94 - $24.12 $1.61 Million - $2.78 Million	115,400 Added 24.66%	583,300 $12.5 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $219,462 - $365,928	15,800 Added 3.49%	467,900 $7.09 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $3.39 Million - $4.27 Million	208,200 Added 85.36%	452,100 $8.77 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $2.58 Million - $4.57 Million	-204,800 Reduced 45.64%	243,900 $5.06 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $3.69 Million - $6.84 Million	-297,700 Reduced 39.88%	448,700 $6.11 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $1.54 Million - $10.2 Million	627,200 Added 526.17%	746,400 $12.1 Million
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $224,852 - $291,972	83,900 Added 237.68%	119,200 $368,000
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $77,142 - $114,552	25,800 Added 271.58%	35,300 $106,000
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $7,038 - $9,407	-2,300 Reduced 19.49%	9,500 $38,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $35,754 - $43,896	11,800	11,800 $41,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.